Tilray Brands, Inc. (NASDAQ:TLRY) named one of the best sin stocks to buy. Jefferies raised price target to $2, citing potential benefits from US cannabis policy changes. The company faces challenges in its alcohol division despite regulatory opportunities in the cannabis sector.

20 States with the Highest Weed Consumption in the US. Jefferies sees potential benefits for cannabis companies from potential rescheduling. The move could ease research opportunities and lower taxation for cannabis companies. Tilray could be a major beneficiary of these regulatory changes, but faces challenges in the alcohol sector.

Tilray Brands, Inc. (NASDAQ:TLRY) is a US-based pharmaceutical, cannabis-lifestyle, and consumer packaged goods company headquartered in New York City. Jefferies highlights potential benefits for the company from US cannabis policy changes. However, they also note challenges in Tilray’s alcohol division.

Investors looking for undervalued AI stocks may find better opportunities than TLRY. Jefferies sees potential upside in certain AI stocks compared to Tilray. The company may face challenges in its alcohol division despite potential benefits from US cannabis policy changes.

For more investment opportunities, check out Insider Monkey’s list of 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds. Disclosure: None. Original article published on Insider Monkey’s website.

Read more at Yahoo Finance: Jefferies Raises Tilray (TLRY) Price Target on Potential Cannabis Rescheduling